MyCEI Login


Update on Mpox and Preventing Future Outbreaks


Published Date: 06/05/2023

Expiration Date: 05/09/2026

CE Credit: CME:1


The explosion of mpox that caught everybody by surprise and most severely affected our immunodeficient patients has receded, but is not gone. It is important now that mpox be included in our pantheon of sexually transmitted infections and include necessary preventive immunization for our patients at risk moving forward.


Preeti Pathela,DrPH, MPH

Preeti Pathela is the Executive Director of the STI Program in the Bureau of Hepatitis, HIV, and STI at the New York City Department of Health and Mental Hygiene, with overall responsibility for directing, evaluating, and coordinating the activities of the Program, which consists of roughly 70 staff who conduct work in STI program implementation, surveillance and field operations, and epidemiology, research and evaluation. She has 18 years of experience in STI/HIV prevention and control, with a previous role of Director of STI Research and Evaluation at the NYC Health Department, during which time she oversaw a unit comprising analysts who examined data on STI/HIV patterns among the program’s sexual health clinic population, as well as at the citywide level, to generate and answer research questions around STD/HIV risk, prevention, and service delivery. She serves on the American STD Association’s Board of Directors and as an Associate Editor of Sexually Transmitted Diseases. Preeti received a DrPH degree in Epidemiology from the Johns Hopkins Bloomberg School of Public Health and her MPH from Emory University.

Learning Objectives

  • Be aware of activities undertaken by the NYC Health Department, during the 2022 mpox outbreak and currently.
  • Understand ongoing community transmission and optimal methods for prevention, diagnosis, and treatment.
  • Know how to access available provider resources.

Continuing Education Credit Information